NCT06395519: A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 120 planned
- Started
- 13 May 2024
- Primary completion
- Dec 2026
- Arms
- Phase 1 Part 1: Monotherapy Dose Escalation, Phase 1 Part 2: Monotherapy Dose Expansion
- Results
- None posted
- 2 May 2024: Trial registered
- 13 May 2024: Trial started